Loading…
Loading…
CFLT (Confluent, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
CFLT does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CFLT and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CFLT and 80,000+ other tickers.
See exactly how CFLT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CFLT and 80,000+ other tickers.
Confluent, Inc. operates a global data streaming platform, serving clients across the United States and internationally. The company's core products include Confluent Cloud, a fully managed, cloud-native service designed for seamlessly connecting and processing data, and Confluent Platform, an enterprise-level, self-managed software solution. This platform acts as the fundamental "data in motion" layer, enabling real-time data integration and processing for businesses. Beyond its main platforms, Confluent provides several specialized tools: Kafka Connect, which allows users to create…
LOUISVILLE, Ky. -- June 16, 2026, June 16, 2026 (GLOBE NEWSWIRE) -- Chronic pain is shaping how millions of Americans live, move, sleep, work, and recover. New findings from Confluent Health suggest the healthcare system may still be falling short in addressing it.
LONDON--(BUSINESS WIRE)--Confluent, an IBM Company and the data streaming pioneer, today announced new capabilities in Confluent Intelligence and Confluent Cloud that streamline how real-time artificial intelligence (AI) applications are built and secured. These updates remove the security and complexity barriers that stop organizations from moving AI workloads into the real world: Confluent unifies the AI life cycle with tools that developers already live in, integrating Apache Flink® pipeline.
SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, has been appointed as Chief Operating Officer ("COO") for the company, effective April 29th, 2026.
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.